Uber, Pfizer, Marriott rise premarket; Tesla, Chegg fall
Get Alerts PFE Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.5%
Revenue Growth %: -1.8%
Join SI Premium – FREE
Investing.com -- Stocks in focus in premarket trade on Tuesday, May 2nd. Please refresh for updates.
Pfizer (NYSE: PFE) stock rose 0.9% after the pharma giant beat first-quarter profit expectations as strong demand for new products helped offset declining sales of its COVID-19 products.
Uber (NYSE: UBER) stock rose 7.9% after the ride-hailing firm reported strong first-quarter results and forecast quarterly core earnings above estimates after a surge in demand for travel and food delivery.
Tesla (NASDAQ: TSLA) stock fell 0.3% after the electric car manufacturer raised prices in Canada, China, Japan, and the United States, its website showed on Monday, after having slashed prices on its top-selling vehicles since the start of the year.
Restaurant Brands (NYSE: QSR) stock rose 0.6% after the company beat expectations for quarterly revenue, boosted by higher prices and increased traffic at its Burger King and Tim Hortons chains.
Chegg (NYSE: CHGG) stock slumped over 41% after the educational services company issued disappointing second-quarter guidance, citing increasing competition from ChatGPT.
Marriott International (NASDAQ: MAR) stock rose 1.8% after the hotel operator raised its full-year profit forecast, citing pent-up demand for leisure and business travel.
HSBC (NYSE: HSBC) ADRs rose 5.8% after the Asia-focused bank reported a tripling in profit in the first quarter, helping the lender pay its first quarterly dividend since 2019.
BP (NYSE: BP) ADRs fell 5.1% after the energy giant slowed the pace of share buybacks, announcing it will repurchase $1.75 billion of shares before announcing second-quarter results, down by $1B from the prior period. Its first-quarter net income came in just under $5B, down from $6.25B a year earlier.
Coinbase (NASDAQ: COIN) stock fell 1.6% after Citigroup downgraded its stance on the cryptocurrency exchange to ‘neutral’ and ‘buy’, seeing a lot of regulatory uncertainty surrounding its story.
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- Aspire Biopharma to acquire automotive supplier for $30 million
- BIG3 Basketball to go public via Graf Global merger at $290 million
Create E-mail Alert Related Categories
Investing, Special ReportsRelated Entities
Citi, HSBC, Tesla, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share